Biomedical subjects

D J Halls

Publications and source records attributed to D J Halls.

21 records · Page 2Linked to original sources

PubMed1982

Studies of lead and cadmium exposure in Glasgow, U.K.

Domestic water and whole blood samples were collected early in 1981 from two hundred volunteers living in the Glasgow area of Scotland, U.K. The concentration of lead in the water and blood samples, and of cadmium in the blood, was measured. The blood lead and cadmium concentrations were compared to those obtained in the Survey of 1979. There has been a fall in blood lead concentrations since the 1979 Survey. In contrast, the blood cadmium levels had remained similar. This diminution in blood lead concentration is attributed to a fall in water lead concentration caused by raising the pH of the water supply in the Glasgow area. The main determinant for cadmium in blood appears to be cigarette smoking habits, which had not changed.

Adolescent↗

PubMed1982

The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.

In a low water aluminium area ( less than or equal to 0.4 micromoles/1) plasma aluminium levels were normal in 31 non-dialyzed and 7 peritoneally-dialyzed patients unless oral aluminium hydroxide was prescribed. Plasma aluminium levels were above normal in 26 patients on maintenance hemodialysis, but when aluminium hydroxide intake stopped there was a decrease in pre-dialysis plasma aluminium. Poor compliers (indicated by plasma phosphate levels) showed no change. Oral aluminium hydroxide can make a major contribution to plasma aluminium levels in patients with renal failure and should be treated with the same caution as high dialyzate aluminium. Post-dialysis plasma aluminium levels were always higher than pre-dialysis levels both on and off aluminium therapy despite the low dialyzate aluminium concentration. This rise may be due to tissue redistribution.

Administration, Oral↗

PubMed1981

Determination of copper in urine by graphite furnace atomic absorption spectrometry.

Two methods are described for the determination of copper in urine by graphite furnace atomic absorption spectrometry. The first, suitable for spectrometers capable of making good background correction at 325 nm, involves a direct determination against simple aqueous standards after 2 X dilution of the sample. The second requires no background correction and can be used when background correction is not available or is inadequate. The copper is extracted from the urine with ammonium tetramethylenedithiocarbamate into methylisobutylketone and the extract is analysed for copper. No significant matrix effect was observed for either method. Analysis of random urine samples from 16 normal subjects gave a mean concentration of 0.42 mumol/l with a range of 0.06--1.04 mumol/l.

Copper↗